» Articles » PMID: 39006382

Quantitative Assessment of Self-management in Patients with Non-alcoholic Fatty Liver Disease: An Unmet Clinical Need

Overview
Specialty Gastroenterology
Date 2024 Jul 15
PMID 39006382
Authors
Affiliations
Soon will be listed here.
Abstract

In this editorial we comment on the article titled "Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease" by Zeng published in a recent issue of the . Non-alcoholic fatty liver disease (NAFLD) represents one of the current challenges in hepatology and public health, due to its continuous growing prevalence and the rising incidence of NAFLD-related fibrosis, non-alcoholic steatohepatitis and cirrhosis. The only effective therapeutic strategy for this disease is represented by encouraging patients to improve their lifestyle through the modification of dietary intake and increased physical exercise, but the effective application of such modifications is often limited by various factors such as lack of information, psychological barriers or poor social support. While poor adherence to a healthy lifestyle can be decisive in determining the clinical outcome, in daily practice there is a lack of quantitative instruments aimed at identifying patients with the lowest adherence to lifestyle changes and higher risk of disease progression in the course of follow-up. In this article, Zeng propose a quantitative scale to assess the grade of adherence of patients with NAFLD to healthy lifestyle intervention, called the Exercise and Diet Adherence Scale (EDAS). This scale, consisting of 33 items divided into 6 dimensions which relates to six subjective aspects in the self-management of NAFLD, has shown a good correlation with the identification of the sub-cohort of patients with the highest reduction in caloric intake, increase in physical exercise, probability of a reduction in liver stiffness measurement and alanine aminotransferase levels. The correlation among clinical outcomes and specific dimensions of this scale also highlights the pivotal role of a good and confidential doctor-patient relationship and of an effective communication. There is an urgent need for practical and effective instruments to assess the grade of self-management of NAFLD patients, together with the development of multidisciplinary teams with the aim of applying structured behavioral interventions.

References
1.
Riazi K, Azhari H, Charette J, Underwood F, King J, Afshar E . The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022; 7(9):851-861. DOI: 10.1016/S2468-1253(22)00165-0. View

2.
Zhou R, Zhang B, Zhang W, Kong T, Fu J, Li J . Self-management behaviours in adults with non-alcoholic fatty liver disease: a cross-sectional survey from China. BMJ Open. 2024; 14(2):e078333. PMC: 10884200. DOI: 10.1136/bmjopen-2023-078333. View

3.
Kwon O, Jang Y, Lee J, Kim S, Ahn S . Development and initial validation of the nonalcoholic fatty liver disease self-management questionnaire. Res Nurs Health. 2021; 44(5):844-853. DOI: 10.1002/nur.22164. View

4.
Harrison S, Bedossa P, Guy C, Schattenberg J, Loomba R, Taub R . A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med. 2024; 390(6):497-509. DOI: 10.1056/NEJMoa2309000. View

5.
Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J . Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002; 48(2):177-87. DOI: 10.1016/s0738-3991(02)00032-0. View